Jennison Associates’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-387,925
Closed -$72.2M 660
2018
Q4
$72.2M Buy
387,925
+49,055
+14% +$10.1M 0.08% 149
2018
Q3
$84.6M Buy
338,870
+213,132
+170% +$51.7M 0.08% 173
2018
Q2
$27.4M Buy
125,738
+43,389
+53% +$8.94M 0.03% 352
2018
Q1
$15.8M Buy
+82,349
New +$15.2M 0.02% 421

Other funds holding IDXX

Jennison Associates's IDXX Position: Q1 2019 in Review

Jennison Associates sold out of Idexx Laboratories (IDXX) in Q1 2019, closing a stake of 387,925 shares — an estimated $72.2M sold.

Jennison Associates first reported a position in IDXX in Q1 2018 and held it in 4 quarters. The position peaked at $84.6M in Q3 2018. 685 funds tracked by Wall St. Rank hold IDXX as of Q1 2019.

  • Jennison Associates reported no remaining Idexx Laboratories position as of Q1 2019 after selling out during the quarter.
  • Jennison Associates sold 387,925 Idexx Laboratories shares in Q1 2019, an estimated $72.2M.
  • Jennison Associates first reported a position in Idexx Laboratories in Q1 2018 and held it in 4 quarters.
  • Jennison Associates's Idexx Laboratories position peaked at $84.6M in Q3 2018.
  • 685 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2019.

Based on Jennison Associates's 13F filing for Q1 2019, filed 10 May 2019.